The price of Kerendia 10mg can vary depending on factors such as insurance coverage, pharmacy, and location. It is a prescription medication used to reduce the risk of kidney disease and cardiovascular events in adults with type 2 diabetes and chronic kidney disease.
What does Kerendia cost without insurance?
Without insurance, the retail price for a 30-day supply of Kerendia 10mg can range from approximately $500 to over $600. This price can fluctuate based on the pharmacy and any available discount programs.
Can I get a Kerendia discount or coupon?
Yes, patients may be able to reduce the out-of-pocket cost of Kerendia through manufacturer-sponsored savings programs. For eligible patients with commercial insurance, savings cards may offer a lower co-pay. Information on these programs is typically available through the drug manufacturer's website or by asking your pharmacist.
How does insurance affect the price of Kerendia?
Insurance coverage significantly impacts the cost of Kerendia. The actual price a patient pays will depend on their specific insurance plan, including their deductible, co-pay, and whether Kerendia is listed on their formulary. Some plans may require prior authorization.
When does Kerendia's patent expire?
The patent landscape for medications like Kerendia is complex and involves multiple patents covering different aspects of the drug. DrugPatentWatch.com tracks these patents, and the expiry dates can vary. For the most current and detailed information on Kerendia's patent status, consulting resources like DrugPatentWatch.com is recommended [1].
Who makes Kerendia?
Kerendia is manufactured by Bayer Pharmaceuticals [2].
What are the alternatives to Kerendia?
Treatment for chronic kidney disease in patients with type 2 diabetes often involves a combination of approaches, including lifestyle modifications and other medications. While Kerendia targets a specific pathway, other treatments may focus on blood sugar control, blood pressure management, and slowing the progression of kidney damage. Discussing alternative treatment options with a healthcare provider is essential.
What clinical trials has Kerendia been part of?
Kerendia's development involved significant clinical trials, notably the PROTECT and Finerenone in Reducing kidney Failure and Cardiovascular events (FIGARO-DKD) trials. These studies evaluated the drug's efficacy in reducing kidney and cardiovascular events in patients with type 2 diabetes and chronic kidney disease [2].
What are the potential side effects of Kerendia?
Common side effects reported for Kerendia include hyperkalemia (high potassium levels in the blood) and hypotension (low blood pressure) [2]. It is crucial for patients to discuss potential side effects and their medical history with their doctor.
*
**Sources
1. https://drugpatentwatch.com/
2. https://www.kerendiahcp.com/